![COSMIC-313](https://www.adcreviews.com/wp-content/uploads/2022/07/COSMIC-313-300x126.jpg)
New Progress Of TKI Combined With Double Immunotherapy For Renal Cancer
Exelixis Announces Cabozantinib in Combination with Nivolumab and Ipilimumab Significantly Improved Progression-Free Survival in Phase 3 COSMIC-313 Pivotal Trial in Patients with Previously Untreated Advanced